Work

PCN200 Using A Weibull Parametric Model for Failure-Time Data to Assess Progression-Free Survival as A Surrogate Endpoint for Overall Survival in A Trial of Patients with Metastatic Renal Cell Carcinoma

Year: 2011

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2011.08.1299

Authors: S. Negrier, A.G. Bushmakin, J.C. Cappelleri, C. Charbonneau, R. Sandin, M.D. Michaelson, R.A. Figlin, R.J. Motzer

Institutions: Centre Léon Bérard, Pfizer (United States), Pfizer (Sweden), Massachusetts General Hospital, Cedars-Sinai Medical Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2065621388

Cites:

Cited by: 1

Related to: 10